Sensimed Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Sensimed General Information

Description

Developer of a unique non-invasive soft contact lens-based platform designed to treat glaucoma and record continuous ocular dimensional change over 24 hours. The company's platform provides an automated recording of ocular dimension changes and uses this data to deliver customized treatment to patients, enabling ophthalmologists to better understand and treat glaucoma.

Contact Information

Website
www.sensimed.ch
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Parent Company
Primary Office
  • Route de Chavannes 37
  • 1007 Lausanne
  • Switzerland
+41 021 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensimed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 24-Dec-2019 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Jul-2013 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 08-Sep-2010 0000 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 17-Dec-2007 $7.12M $7.12M Completed Startup
1. Debt - General 01-Jan-2003 Completed Startup
To view Sensimed’s complete valuation and funding history, request access »

Sensimed Patents

Sensimed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210204811-A1 Intraocular pressure measuring andior monitoring device Pending 06-Jul-2018 00000000
AU-2018431330-A1 Intraocular pressure measuring and/or monitoring device Pending 06-Jul-2018 00000000
CA-3104772-A1 Intraocular pressure measuring and/or monitoring device Pending 06-Jul-2018 00000000
EP-3817643-A1 Intraocular pressure measuring and/or monitoring device Pending 06-Jul-2018 00000000
EP-3638094-A1 Device and methods for monitoring a visual field progression of a user Pending 14-Jun-2017 A61B3/0025
To view Sensimed’s complete patent history, request access »

Sensimed Executive Team (9)

Name Title Board Seat Contact Info
Olivier Taburet Chief Financial Officer
Sacha Cerboni Co-Founder and Chief Quality Officer
Raphael Fritschi Ph.D Head of MEMS Sensor Development
You’re viewing 3 of 9 executive team members. Get the full list »

Sensimed Board Members (12)

Name Representing Role Since
Agnes LeSaux-Narjoz Self Board Member 000 0000
André Mueller Self Board Member 000 0000
Claude Claret Ph.D Self Board Member 000 0000
David Bailey Sensimed Board Member & Chief Executive Officer 000 0000
Erich Schlick Wellington Partners Co-Chairman 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Sensimed Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agate Medical Investments Venture Capital Minority 000 0000 000000 0
BlueOcean Ventures Venture Capital Minority 000 0000 000000 0
ELM Development Real Estate Minority 000 0000 000000 0
GoBeyond Angel Group Minority 000 0000 000000 0
Hans JoergWyss Holdings Other Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »